Literature DB >> 30389722

Is There Sufficient Evidence that the Melatonin Binding Site MT3 Is Quinone Reductase 2?

Jean A Boutin1, Gilles Ferry2.   

Abstract

In the 1980s, researchers used binding studies to show that there is a melatonin binding site in addition to the receptors described previously. It was first termed ML2 and then, in 1999, MT3 Purification efforts led to its identification as quinone reductase 2. Several lines of evidence support the notion that MT3 is the same as quinone reductase 2, including the detection and characterization of MT3 whenever quinone reductase 2 was added to various systems under various conditions. This evidence is discussed in this review, which summarizes the results of relevant cellular and animal experiments. The recent discovery that the quinone reductase 2 enzyme can be partly membrane-associated may unite the current body of evidence and allow us to conclude definitively that the third melatonin binding site, MT3 , is indeed quinone reductase 2.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30389722     DOI: 10.1124/jpet.118.253260

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Melatonin Binding to Human NQO2 by Isothermal Titration Calorimetry.

Authors:  Barbara Calamini; Gilles Ferry; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

2.  Measuring Binding at the Putative Melatonin Receptor MT3.

Authors:  Céline Legros; Philippe Dupuis; Gilles Ferry; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

3.  Alternative Ligands at Melatonin Receptors.

Authors:  Céline Legros; Said Yous; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

4.  Measurement of NQO2 Catalytic Activity and of Its Inhibition by Melatonin.

Authors:  Gilles Ferry; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Insight of Melatonin: The Potential of Melatonin to Treat Bacteria-Induced Mastitis.

Authors:  Hongyang Li; Peng Sun
Journal:  Antioxidants (Basel)       Date:  2022-06-02

6.  Melatonin delays ovarian aging in mice by slowing down the exhaustion of ovarian reserve.

Authors:  Chan Yang; Qinghua Liu; Yingjun Chen; Xiaodong Wang; Zaohong Ran; Fang Fang; Jiajun Xiong; Guoshi Liu; Xiang Li; Liguo Yang; Changjiu He
Journal:  Commun Biol       Date:  2021-05-06

7.  SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin.

Authors:  Grazia Ilaria Caruso; Simona Federica Spampinato; Giuseppe Costantino; Sara Merlo; Maria Angela Sortino
Journal:  Biomedicines       Date:  2021-04-24

8.  Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum.

Authors:  Yuguang Zhao; Jingshan Ren; James Hillier; Margaret Jones; Weixian Lu; Edith Yvonne Jones
Journal:  J Pineal Res       Date:  2020-01-24       Impact factor: 13.007

Review 9.  Melatonin Target Proteins: Too Many or Not Enough?

Authors:  Lei Liu; Nedjma Labani; Erika Cecon; Ralf Jockers
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-15       Impact factor: 5.555

Review 10.  Melatonin Synthesis and Function: Evolutionary History in Animals and Plants.

Authors:  Dake Zhao; Yang Yu; Yong Shen; Qin Liu; Zhiwei Zhao; Ramaswamy Sharma; Russel J Reiter
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.